Recommended Protocol for Testosterone Injection Therapy
For testosterone replacement therapy via injection, the recommended protocol is to administer testosterone cypionate or enanthate at 50-200 mg intramuscularly every 2 weeks, or 50 mg weekly, with injections given deep in the gluteal muscle. 1, 2
Diagnostic Criteria Before Initiating Therapy
- Confirm testosterone deficiency with:
Injection Protocol Details
Medication Options
- Testosterone cypionate (100 mg/mL or 200 mg/mL) 1
- Testosterone enanthate (200 mg/mL) 4
- Testosterone undecanoate (250 mg/mL): 750 mg initially, followed by 750 mg after 4 weeks, then 750 mg every 10 weeks 3
Administration Technique
- Intramuscular injection only (never intravenous) 1
- Injection site: Deep in the gluteal muscle 1
- Self-injection: Thigh is recommended site 2
- When administered by another person: Gluteal administration 2
Dosing Schedule
- Standard dosing: 100-200 mg every 2 weeks or 50 mg weekly 2, 1
- Dosage range for hypogonadal males: 50-400 mg every 2-4 weeks 1
- Target mid-normal testosterone level: 450-600 ng/dL 2, 3
Monitoring Protocol
Initial Monitoring (3-6 months)
- Testosterone levels: Measure midway between injections, targeting 500-600 ng/dL 2, 3
- Hematocrit: Discontinue if exceeds 54% 3
- PSA: Biopsy if >4.0 ng/mL or increases >1.0 ng/mL/year 3
- Symptom response evaluation 3
Long-term Monitoring (every 6-12 months)
Advantages and Disadvantages of Injectable Testosterone
Advantages
- Relatively inexpensive compared to other formulations 2
- Flexible/infrequent dosing 2
- No risk of transference to others 2
- Higher patient compliance due to less frequent administration 2
Disadvantages
- Requires intramuscular injection 2
- Fluctuating serum testosterone levels with peaks and valleys 2
- Potentially greater risk of cardiovascular events compared to gels 2
- Time spent in both supratherapeutic and subtherapeutic ranges between injections 2
Important Considerations and Precautions
- Contraindications: Breast or prostate cancer, hematocrit >50%, severe untreated sleep apnea, severe lower urinary tract symptoms, uncontrolled heart failure 3
- Not recommended for men with desire for current or future fertility 3
- Discontinue if no improvement in sexual function within 12 months 3
- Consider therapeutic phlebotomy for rapid correction of elevated hematocrit levels 3
- Inspect solution visually for particulate matter before administration 1
- Warming and shaking the vial should redissolve any crystals that may have formed during storage 1
Alternative Formulations to Consider
If injections are not suitable, consider:
- Transdermal gels (1-1.62%): 50-100 mg/day applied to skin of back, abdomen, upper thighs, and upper arms 2
- Transdermal patches: 2-6 mg/day applied to dry, intact skin 2
- Subcutaneous implants (pellets): 150-450 mg every 3-6 months 2
Injectable testosterone remains a common and effective method for testosterone replacement therapy, particularly when cost and convenience are important considerations, despite potential fluctuations in hormone levels between doses.